A Phase I, Multi-Center, Open-Label Study to Examine the Pharmacokinetics of a Single Dose of Droxidopa in Subjects With Renal Impairment Compared to Healthy Volunteers

Trial Profile

A Phase I, Multi-Center, Open-Label Study to Examine the Pharmacokinetics of a Single Dose of Droxidopa in Subjects With Renal Impairment Compared to Healthy Volunteers

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 28 Mar 2013

At a glance

  • Drugs Droxidopa (Primary)
  • Indications Attention-deficit hyperactivity disorder; Chronic fatigue syndrome; Fibromyalgia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Mar 2012 Planned end date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 07 Mar 2012 Planned initiation date changed from 1 Jun 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
    • 14 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top